You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

TAZAROTENE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Tazarotene

A generic version of TAZAROTENE was approved as tazarotene by TARO on April 3rd, 2017.

  Try a Trial

Drug patent expirations by year for TAZAROTENE
Drug Prices for TAZAROTENE

See drug prices for TAZAROTENE

Recent Clinical Trials for TAZAROTENE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ortho DermatologicsPhase 4
Dermatology Consulting Services, PLLCPhase 4
Zagazig UniversityPhase 2

See all TAZAROTENE clinical trials

Pharmacology for TAZAROTENE
Drug ClassRetinoid
Paragraph IV (Patent) Challenges for TAZAROTENE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ARAZLO Topical Lotion tazarotene 0.045% 211882 1 2022-05-12

US Patents and Regulatory Information for TAZAROTENE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cosette TAZAROTENE tazarotene CREAM;TOPICAL 208662-001 Dec 22, 2017 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Padagis Israel TAZAROTENE tazarotene GEL;TOPICAL 213079-002 Apr 25, 2023 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Cosette TAZAROTENE tazarotene GEL;TOPICAL 215433-001 Sep 13, 2022 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Solaris Pharma Corp TAZAROTENE tazarotene GEL;TOPICAL 213644-001 Mar 20, 2023 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.